Literature DB >> 1169

Plasma concentrations and the time-course of beta blockade due to propranolol.

D G McDevitt, D G Shand.   

Abstract

The effectiveness of intravenously administered propranolol in antagonizing the chronotropic effect of isoproterenol and exercise has been investigated, and has been found at all times to be a predictable function of its plasma concentrations according to the classical drug-receptor theory for competitive antagonism. The data show further that the relationship between effectiveness and time depends on the way in which antagonism is measured. If the dose ratio to isoproterenol (DR) is measured, then (DR-1) declines with time in parallel with drug concentration. On the other hand, if propranolol's effects are measured as percentage reduction in a given response, then this declines linearly with time, even though plasma concentrations decline exponentially. This fact explains why confusion has in the past arisen concerning the relationship of the duration of beta blockade and pharmacokinetic half-life.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1169     DOI: 10.1002/cpt1975186708

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  30 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Concentration-effect and dose-response relations in clinical pharmacology.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-03       Impact factor: 4.335

Review 3.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.

Authors:  T Ishizaki; K Tawara
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

6.  Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).

Authors:  R A Vukovich; J E Foley; B Brown; D A Willard; M Buckley; D O'Kelly; D Fitzgerald; W Tormey; A Darragh
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 7.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

8.  Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.

Authors:  R Lochan; B Silke; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

9.  Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.

Authors:  R G Wilcox; J R Hampton
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

10.  Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.

Authors:  N Himori; S Honma; A Izumi; T Ishimori
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.